Juvenescence
Juvenescence is a clinical-stage drug development company that creates small molecules, biologics, and cell therapies designed to target core aging mechanisms. The company focuses on early disease intervention and prevention to treat age-related conditions and extend human healthspan. Its research and development process integrates AI and data science tools to design novel compounds and manage adaptive clinical trials.
Visit websiteRamsey, UK
Biotechnology
Pharmaceuticals
Life Sciences
Longevity
Healthtech
Funding summary
- Total raised
- €66.7M
- Funding rounds
- 1
Investors in Juvenescence
Investors on record for Juvenescence. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Juvenescence?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors